Delivery Order SPE2DB22D3004-SPE2DB24FQB03
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a firm fixed price of $4,502.20 and a completion date of April 16, 2024. Amerisourcebergen Drug Corp. has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,652.35 firm fixed price contract is for the supply of Dupixent 300 mg/2 ml pens, with an ultimate completion date of April 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025 to provide a wide range of...
- This is a Delivery Order worth $18,633.71 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of October 16, 2024 and is a Firm Fixed Price (FFP) contract type. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical program, valued at up to $999,999,999...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $34,879.29, is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary contract vehicle for the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml. The $3,304.72 contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA, which serves as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen. The contract has a firm fixed price of $6,356.88 and a period of performance through May 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the specialty pharmaceutical product Dupixent 300 mg/2 ml pen in support of military treatment programs and facilities. The delivery order, valued at $9,448.68, has a performance period through March 20, 2024. Amerisourcebergen Drug Corp holds a much larger indefinite delivery contract with...
- This firm fixed-price delivery order, valued at $87,620.32, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml Pen 2 ml. The award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of a pharmaceutical product, Dupixent 300 mg/2 ml pen 2 ml. The contract is a firm fixed-price delivery order with a ceiling value of $92,236.42 and an ultimate completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract does not have a set-aside designation. This delivery order appears to...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $3,418.92 and a completion date of December 12, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQB03Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The order has a firm fixed price of $3,304.72 and a completion date of April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. This delivery order is not designated as a set-aside contract. Amerisourcebergen's expertise in pharmaceutical distribution and its established relationship with the DLA allow it to efficiently fulfill government contracts for critical medical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/18/24 |